← Open Payments lookup

JAMES EAKIN: Open Payments

NPI 1023688769 · YAKIMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$378 in 16 payments from 8 companies in 2025. Trend: 2023 $75 · 2024 $117 · 2025 $378

Food & beverage: $378
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.6$107
Janssen Pharmaceuticals, Inc2$65
E.R. Squibb & Sons, L.L.C.2$62
Teva Pharmaceuticals USA, Inc.2$48
Neurocrine BioSciences, Inc.1$27
Lundbeck LLC1$25
Axsome Therapeutics, Inc.1$25
Neuronetics, Inc.1$19

Products named: Qelbree, INVEGA SUSTENNA, COBENFY, AUSTEDO XR, INGREZZA, REXULTI, Auvelity, NEUROSTAR TMS THERAPY SYSTEM.

Industry payments across WA — which companies pay providers there.